News

TussiCaps, which is approved by the FDA, is now available by prescription in 10mg/8mg capsules through wholesalers and pharmacies in the US. TussiCaps extended-release capsules are indicated for

In this role, Mr Moreno is responsible for developing and implementing strategic initiatives to grow the company’s business throughout the Americas, Europe and Asia. He is based in

As one of four suppliers of cryoprecipitate in China, China Biologic has been engaged in a contract to supply cryoprecipitate to Green Cross China for use in the

Memory Pharmaceuticals is currently conducting a Phase II trial of R3487/MEM 3454 in cognitive impairment associated with schizophrenia (CIAS), and the companies have agreed to expand the study

Depomed’s Phase III registration program for Gabapentin GR in menopausal hot flashes includes two randomized, double-blind, placebo-controlled studies of approximately 540 patients per study. In each study, patients

Under the terms of the agreement, Biovail has paid $100 million to acquire 100% of Prestwick Pharmaceuticals and related license rights. Beyond Xenazine, the acquisition also provides Biovail

The Phase IIb study is a randomized, double-blind, placebo-controlled study that is designed to assess the safety and efficacy of Xiaflex, when administered two times a week every

Dr Soni joins Amarin from Pfizer where he held a number of leadership roles in Pfizer global R&D in both experimental medicine and late stage development. Amarin has

The CINtec cytology kit is an immuno-cytochemistry assay for the qualitative detection of the p16INK4a antigen on cervical cytology preparations. It is intended to be used as an